Dolabellane, a biogenetic precursor of fusicoccane and dolastane diterpenoids, was constructed stereoselectively via Cope rearrangement of an appropriately functionalized 1,3,2-dioxasilacycloheptane derivative to generate the trans-geometry at C-1 and C-12.